Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment
Author:
Meng Feiyu,
Yang Yang,
Wang Xinyu,
Cai Fenglin,
Liang Han,
Zhang Rupeng,
Deng JingyuORCID
Reference42 articles.
1. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study;Mokadem;Gastric Cancer,2019
2. Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy;Ikoma;Ann Surg Oncol,2017
3. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006
4. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011
5. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial